Drug Type Small molecule-drug conjugates |
Synonyms- |
Target |
Action inhibitors |
Mechanism JAK2 inhibitors(Tyrosine-protein kinase JAK2 inhibitors), STAT3 inhibitors(Signal transducer and activator of transcription 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | China | 18 Sep 2024 |





